PT Ikapharmindo Putramas Tbk (IDX:IKPM)

Market Cap	347.04B
Revenue (ttm)	405.03B
Net Income (ttm)	671.49M
Shares Out	1.68B
EPS (ttm)	0.40
PE Ratio	516.82
Forward PE	n/a
Dividend	2.25 (1.09%)
Ex-Dividend Date	n/a

Volume	1,051,200
Average Volume	140,590
Open	208.00
Previous Close	206.00
Day's Range	192.00 - 210.00
52-Week Range	195.00 - 308.00
Beta	n/a
RSI	39.54
Earnings Date	Aug 1, 2025

About IDX:IKPM

PT Ikapharmindo Putramas Tbk engages in the research and development, manufacturing, and marketing of pharmaceutical products in Indonesia. It operates through three segments: Non Pharma, Pharma, and Contract Manufacturing. The company offers prescription medicines in the areas of neurology, psychiatry, dermatology, nephrology, gastroenterology, cardiology, pulmonology, antibiotics, generics, and nutraceuticals; and over-the-counter drugs. It also provides consumer health products, cosmetics, hair care products, and baby care products. PT Ikaph...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 1978
• Employees: 1,046
• Stock Exchange: Indonesia Stock Exchange
• Ticker Symbol: IKPM

Financial Performance

In 2024, IDX:IKPM's revenue was 412.07 billion, a decrease of -6.59% compared to the previous year's 441.14 billion. Earnings were 5.01 billion, a decrease of -67.30%.